Gregory Troiano MS

Greg serves as Chief Manufacturing Officer at Translate Bio, a Sanofi company, where he is responsible for strategic oversight of all aspects of cGMP CMC operations, including clinical supply, analytical testing, quality, and engineering. Prior to TBio, Greg was Vice President of Technology and Chief Engineer at Seer, a life sciences and health data company using nanotechnology for proteomics and biomarker discovery.

Prior to Seer, Greg was Vice President of Nanomedicine Development and Manufacturing within Pfizer’s Pharmaceutical Sciences group, leading the development and manufacturing of novel nanoparticle drug products. Over his 20+ year career in the drug delivery field, Greg had various roles leading the pharmaceutical development of complex formulations, including numerous nano- and microparticle-based systems.